Syndax Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Syndax Pharmaceuticals Inc
TickerSNDX
CIK #0001395937
CUSIP87164F105
SectorLife Sciences - Pharmaceutical Preparations
Address460 Totten Pond Road Suite 650, Waltham, MA 02451
Source [EDGAR]
CIK Filing 2011 - 2024
[0001395937] 10-K
[0001395937] 10-Q
[0001395937] 3
[0001395937] 4
[0001395937] 8-K
[0001395937] D
[0001395937] SC 13D
[0001395937] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Wellington Management Group LLP Syndax Pharmaceuticals Inc [2023-01-10] 11.72
Nantahala Capital Management LLC Syndax Pharmaceuticals Inc [2022-02-14] 5.8
Frazier Life Sciences Public Fund LP Syndax Pharmaceuticals Inc [2021-12-23] 3.2
Adage Capital Partners GP LLC Syndax Pharmaceuticals Inc [2021-05-10] 5.6
Access Industries Holdings LLC Syndax Pharmaceuticals Inc [2021-05-03] 5.56
BlackRock Inc Syndax Pharmaceuticals Inc [2021-02-02] 5.0
Avidity Partners Management LP Syndax Pharmaceuticals Inc [2020-11-04] 6.7
Boxer Capital LLC Syndax Pharmaceuticals Inc [2020-05-11] 0.0
Access Industries Holdings LLC Syndax Pharmaceuticals Inc [2019-10-09] 6.1
Adage Capital Partners GP LLC Syndax Pharmaceuticals Inc [2019-04-08] 5.72
BlackRock Inc Syndax Pharmaceuticals Inc [2019-02-08] 6.3
683 Capital Management LLC Syndax Pharmaceuticals Inc [2018-11-29] 5.0
Biotechnology Value Fund L P Syndax Pharmaceuticals Inc [2017-11-14] 3.9
Wellington Management Group LLP Syndax Pharmaceuticals Inc [2016-09-12] 11.0
FMR LLC Syndax Pharmaceuticals Inc [2016-04-11] 0.0
Form 3/4/5 Filer 2011 - 2024
Goldan Keith A.
Syndax Pharmaceuticals Inc
Morrison Briggs
Gallagher Neil
Ordentlich Peter
Metzger Michael A
Nolte Alexander
Madigan Catherine
Podlesak Dennis
Huber Martin H. Jr.
Meury William
Legault Pierre
Katkin Keith
Jarrett Jennifer
Sabus Steve M
Meyers Michael L.
Egros Fabrice
Karydas Daphne
Shea Richard P
Lampert Mark N
Biotechnology Value Fund II LP
BVF Partners OS Ltd.
BVF Inc/IL
BVF Partners L P/IL
Biotechnology Value Trading Fund OS LP
Biotechnology Value Fund L P
Chen Henry
Evnin Luke
Sledge George W. Jr.
Kamdar Kim P.
Royston IVOR
MPM Asset Management Investors BV4 LLC
MPM BioVentures IV Strategic Fund, L.P.
Scopa James Paul
Gadicke Ansbert
MPM BioVentures IV GP LLC
MPM BioVentures IV LLC
MPM BioVentures IV GmbH & Co. Beteiligungs KG
Kailian Vaughn M
MPM BioVentures IV QP LP
Foley Todd
Treu Jesse I
Dovey Brian H
Vitullo Nicole
Blair James C
Domain Partners VI, L.P.
DP VIII Associates, L.P.
Halak Brian K
DP VI Associates, L.P.
Domain Partners VIII, L.P.
Shaw Allan
Domain Associates
Shah Nimesh
Form 13F Holdings
Firm Period DFND Voting Shares
Wellington Management Group LLP [2023-03-31] DFND 0.0 7,003,734.0
BlackRock Inc. [2023-03-31] SOLE 4,783,283.0 4,900,841.0
State Street Corp [2023-03-31] DFND 3,747,413.0 3,866,230.0
Avidity Partners Management LP [2023-03-31] SOLE 3,865,300.0 3,865,300.0
Frazier Life Sciences Management LP [2023-03-31] SOLE 3,708,838.0 3,708,838.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 3,390,885.0
Kynam Capital Management LP [2023-03-31] SOLE 3,205,986.0 3,205,986.0
Avoro Capital Advisors LLC [2023-03-31] SOLE 2,650,000.0 2,650,000.0
Paradigm Biocapital Advisors LP [2023-03-31] SOLE 2,274,512.0 2,274,512.0
Jennison Associates LLC [2023-03-31] DFND 2,213,629.0 2,213,629.0
Eversept Partners LP [2023-03-31] SOLE 2,209,057.0 2,209,057.0
BVF Inc/IL [2023-03-31] DFND 0.0 2,143,197.0
PFM Health Sciences LP [2023-03-31] DFND 0.0 1,946,652.0
OrbiMed Advisors LLC [2023-03-31] DFND 401,200.0 1,711,675.0
Citadel Advisors LLC [2023-03-31] DFND 1,598,669.0 1,598,669.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 1,194,306.0 1,250,174.0
Geode Capital Management LLC [2023-03-31] DFND 1,227,601.0 1,227,601.0
Morgan Stanley [2023-03-31] DFND 1,059,011.0 1,093,844.0
Sofinnova Investments Inc [2023-03-31] SOLE 1,075,424.0 1,075,424.0
Aisling Capital Management LP [2023-03-31] SOLE 1,025,000.0 1,025,000.0
T. Rowe Price Investment Management, Inc. [2023-03-31] SOLE 391,315.0 1,000,715.0
Barclays PLC [2023-03-31] SOLE 981,886.0 981,886.0
Nantahala Capital Management LLC [2023-03-31] SOLE 975,705.0 975,705.0
Braidwell LP [2023-03-31] SOLE 920,049.0 920,049.0
Foresite Capital Management IV, LLC [2023-03-31] SOLE 875,000.0 875,000.0
Commodore Capital LP [2023-03-31] SOLE 853,884.0 853,884.0
Adage Capital Partners GP LLC [2023-03-31] SOLE 790,000.0 790,000.0
Sphera Funds Management Ltd [2023-03-31] DFND 683,061.0 683,061.0
Citigroup Inc [2023-03-31] DFND 620,215.0 620,215.0
Palo Alto Investors LP [2023-03-31] SOLE 612,600.0 612,600.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com